Relationship between serum cytokines receptors and matrix metalloproteinase 9 levels and coronary artery disease
- 2 December 2016
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 31 (5) , e22100
Abstract
The prevalence of coronary artery disease (CAD) is increasing globally, supporting the need for the identification of novel biomarkers. Therefore in the present study, we have explored the association of SIL2A, SIL6R, STNFRI, STNFRII, and MMP9 in CAD patients. Twenty one patients with angiographically defined CAD with more than 50% occlusion, at least, in one coronary artery and twenty healthy subjects (n=20) without the history of cardiovascular symptoms were enrolled. Demographic and biochemical analysis (e.g. Total Cholesterol (TC), Triglyceride (TG), and HDL-C) were measured in all the subjects. The level of cytokines receptor (SIL2A, SIL6R, SIL6R, STNFRI, STNFRII, and matrix metallopeptidase 9 (MMP9) were evaluated. Our results showed the higher level of MMP9 in patients group compared to the control subjects, while no significant differences were detected for other cytokines. In particular the level of MMP9 was significantly (P=.015) increased from 181.16 ng/mL (95%CI: 112.1-199.2) to 192.0 ng/mL (95%CI: 181.5-265.2). Moreover, the sensitivity and specificity of MMP9 were 95.45% and 45%, respectively, as detected by receiver operating characteristic (ROC) curves. We demonstrate the significant correlation of MMP-9 with CAD with sensitivity of 95.45%, suggesting its role as a biomarker in CAD patients. Further studies in larger population – preferably multicenter setting – are warranted to explore the functional role of this marker in coronary artery disease.Keywords
Funding Information
- Mashhad University of Medical Sciences
This publication has 17 references indexed in Scilit:
- Soluble Interleukin-6 Receptor-Mediated Innate Immune Response to DNA and RNA VirusesJournal of Virology, 2013
- Association of Genetic Polymorphisms in Matrix Metalloproteinase-9 and Coronary Artery Disease in the Chinese Han Population: A Case–Control StudyGenetic Testing and Molecular Biomarkers, 2013
- Coronary artery disease in 2010European Heart Journal Supplements, 2010
- Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery diseaseBiomarkers, 2009
- Cytokines and Coronary Artery DiseaseCritical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 2008
- Coronary artery disease in the developing worldAmerican Heart Journal, 2004
- Cytokines and Cytokine Receptors in Advanced Heart FailureCirculation, 2001
- Circulating Levels of Cytokines and Their Endogenous Modulators in Patients With Mild to Severe Congestive Heart Failure Due to Coronary Artery Disease or HypertensionJACC, 1996
- Circulating concentrations of proinflammatory cytolcines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1996
- Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart FailureCirculation, 1995